|
ASX - By Stock
|
TRI |
Re:
Ann: Dr Danielle Meyrick appointed as CEO
|
|
DDD24
|
7 |
2.1K |
1 |
12/05/26 |
| 12/05/26 |
ASX - By Stock
|
7
|
2.1K
|
1
|
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
DDD24
|
19K |
9.5M |
9 |
12/05/26 |
| 12/05/26 |
ASX - By Stock
|
19K
|
9.5M
|
9
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Oncology Options Expiry Reminder
|
|
DDD24
|
119 |
26K |
6 |
08/05/26 |
| 08/05/26 |
ASX - By Stock
|
119
|
26K
|
6
|
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Dr Danielle Meyrick appointed as CEO
|
|
DDD24
|
7 |
2.1K |
2 |
08/05/26 |
| 08/05/26 |
ASX - By Stock
|
7
|
2.1K
|
2
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
DDD24
|
16K |
6.1M |
24 |
05/05/26 |
| 05/05/26 |
General
|
16K
|
6.1M
|
24
|
|
|
ASX - By Stock
|
ENP |
Re:
Ann: TRP 8802 delivers 75% breakthrough response in IBS
|
|
DDD24
|
26 |
4.4K |
1 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
26
|
4.4K
|
1
|
|
|
ASX - By Stock
|
ENP |
Re:
Ann: TRP 8802 delivers 75% breakthrough response in IBS
|
|
DDD24
|
26 |
4.4K |
1 |
04/05/26 |
| 04/05/26 |
ASX - By Stock
|
26
|
4.4K
|
1
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: First Site Activated in Nyradas PROTECT-MI Phase IIa Trial
|
|
DDD24
|
149 |
26K |
5 |
01/05/26 |
| 01/05/26 |
ASX - By Stock
|
149
|
26K
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
down?
|
|
DDD24
|
125 |
57K |
4 |
30/04/26 |
| 30/04/26 |
ASX - By Stock
|
125
|
57K
|
4
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: First Site Activated in Nyradas PROTECT-MI Phase IIa Trial
|
|
DDD24
|
149 |
26K |
8 |
30/04/26 |
| 30/04/26 |
ASX - By Stock
|
149
|
26K
|
8
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
DDD24
|
16K |
6.1M |
5 |
30/04/26 |
| 30/04/26 |
General
|
16K
|
6.1M
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
DDD24
|
121 |
46K |
6 |
30/04/26 |
| 30/04/26 |
ASX - By Stock
|
121
|
46K
|
6
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
DDD24
|
121 |
46K |
3 |
30/04/26 |
| 30/04/26 |
ASX - By Stock
|
121
|
46K
|
3
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
DDD24
|
33K |
12M |
1 |
28/04/26 |
| 28/04/26 |
ASX - By Stock
|
33K
|
12M
|
1
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Oncology Research Symposium Sydney
|
|
DDD24
|
66 |
22K |
18 |
27/04/26 |
| 27/04/26 |
ASX - By Stock
|
66
|
22K
|
18
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Oncology Research Symposium Sydney
|
|
DDD24
|
66 |
22K |
37 |
26/04/26 |
| 26/04/26 |
ASX - By Stock
|
66
|
22K
|
37
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
DDD24
|
33K |
12M |
5 |
25/04/26 |
| 25/04/26 |
ASX - By Stock
|
33K
|
12M
|
5
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
DDD24
|
33K |
12M |
13 |
24/04/26 |
| 24/04/26 |
ASX - By Stock
|
33K
|
12M
|
13
|
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Key management changes
|
|
DDD24
|
4 |
2.0K |
1 |
21/04/26 |
| 21/04/26 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
DDD24
|
166 |
46K |
3 |
21/04/26 |
| 21/04/26 |
ASX - By Stock
|
166
|
46K
|
3
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
DDD24
|
166 |
46K |
1 |
20/04/26 |
| 20/04/26 |
ASX - By Stock
|
166
|
46K
|
1
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
DDD24
|
16K |
6.1M |
9 |
19/04/26 |
| 19/04/26 |
General
|
16K
|
6.1M
|
9
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
DDD24
|
16K |
6.1M |
0 |
19/04/26 |
| 19/04/26 |
General
|
16K
|
6.1M
|
0
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
DDD24
|
16K |
6.1M |
4 |
19/04/26 |
| 19/04/26 |
General
|
16K
|
6.1M
|
4
|
|
|
ASX - By Stock
|
NYR |
Re:
CHART
|
|
DDD24
|
3.5K |
605K |
4 |
19/04/26 |
| 19/04/26 |
ASX - By Stock
|
3.5K
|
605K
|
4
|
|
|
ASX - By Stock
|
NYR |
Re:
CHART
|
|
DDD24
|
3.5K |
605K |
3 |
19/04/26 |
| 19/04/26 |
ASX - By Stock
|
3.5K
|
605K
|
3
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
DDD24
|
124 |
22K |
6 |
16/04/26 |
| 16/04/26 |
ASX - By Stock
|
124
|
22K
|
6
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Singapore and HK Investor Briefing Update
|
|
DDD24
|
27 |
10K |
1 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
27
|
10K
|
1
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
DDD24
|
124 |
22K |
6 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
124
|
22K
|
6
|
|
|
ASX - By Stock
|
NYR |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
DDD24
|
124 |
22K |
6 |
15/04/26 |
| 15/04/26 |
ASX - By Stock
|
124
|
22K
|
6
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Singapore and HK Investor Briefing Update
|
|
DDD24
|
27 |
10K |
3 |
14/04/26 |
| 14/04/26 |
ASX - By Stock
|
27
|
10K
|
3
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Oncology Research Symposium Sydney
|
|
DDD24
|
66 |
22K |
10 |
11/04/26 |
| 11/04/26 |
ASX - By Stock
|
66
|
22K
|
10
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
DDD24
|
16K |
6.1M |
1 |
09/04/26 |
| 09/04/26 |
General
|
16K
|
6.1M
|
1
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
DDD24
|
16K |
6.1M |
0 |
09/04/26 |
| 09/04/26 |
General
|
16K
|
6.1M
|
0
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
DDD24
|
16K |
6.1M |
9 |
09/04/26 |
| 09/04/26 |
General
|
16K
|
6.1M
|
9
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
DDD24
|
3.8K |
1.3M |
12 |
07/04/26 |
| 07/04/26 |
ASX - By Stock
|
3.8K
|
1.3M
|
12
|
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
DDD24
|
811 |
293K |
2 |
04/04/26 |
| 04/04/26 |
ASX - By Stock
|
811
|
293K
|
2
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
DDD24
|
10 |
4.2K |
0 |
02/04/26 |
| 02/04/26 |
ASX - By Stock
|
10
|
4.2K
|
0
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
DDD24
|
10 |
4.2K |
6 |
02/04/26 |
| 02/04/26 |
ASX - By Stock
|
10
|
4.2K
|
6
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Hong Kong Site Activated for Phase 3 OA Study
|
|
DDD24
|
64 |
19K |
3 |
02/04/26 |
| 02/04/26 |
ASX - By Stock
|
64
|
19K
|
3
|
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Achieves 50% Patient Dosing in Phase 3
|
|
DDD24
|
166 |
46K |
4 |
02/04/26 |
| 02/04/26 |
ASX - By Stock
|
166
|
46K
|
4
|
|
|
ASX - By Stock
|
NYR |
Re:
CHART
|
|
DDD24
|
3.5K |
605K |
0 |
30/03/26 |
| 30/03/26 |
ASX - By Stock
|
3.5K
|
605K
|
0
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
DDD24
|
33K |
12M |
0 |
24/03/26 |
| 24/03/26 |
ASX - By Stock
|
33K
|
12M
|
0
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura HARNESS-1 Trial Receives Governance Approval
|
|
DDD24
|
67 |
21K |
2 |
23/03/26 |
| 23/03/26 |
ASX - By Stock
|
67
|
21K
|
2
|
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
DDD24
|
33K |
12M |
2 |
23/03/26 |
| 23/03/26 |
ASX - By Stock
|
33K
|
12M
|
2
|
|
|
ASX - By Stock
|
NYR |
Re:
CHART
|
|
DDD24
|
3.5K |
605K |
2 |
21/03/26 |
| 21/03/26 |
ASX - By Stock
|
3.5K
|
605K
|
2
|
|
|
ASX - By Stock
|
NYR |
Re:
CHART
|
|
DDD24
|
3.5K |
605K |
2 |
21/03/26 |
| 21/03/26 |
ASX - By Stock
|
3.5K
|
605K
|
2
|
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
DDD24
|
3.2K |
1.1M |
2 |
21/03/26 |
| 21/03/26 |
ASX - By Stock
|
3.2K
|
1.1M
|
2
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Investor Briefing Hong Kong and Singapore
|
|
DDD24
|
108 |
31K |
13 |
21/03/26 |
| 21/03/26 |
ASX - By Stock
|
108
|
31K
|
13
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Racura Investor Briefing Hong Kong and Singapore
|
|
DDD24
|
108 |
31K |
16 |
21/03/26 |
| 21/03/26 |
ASX - By Stock
|
108
|
31K
|
16
|
|